Opening Asia for Russia

Azerbaijan to start research on joint use of Sputnik V and AstraZeneca

09.02.2021 99 просмотров

Azerbaijan allows research on combination of Sputnik V and AstraZeneca vaccines


Azerbaijan has issued permission to conduct the world's first study of a combination of coronavirus vaccines - Sputnik V and AstraZeneca, according to a press release from the Russian Direct Investment Fund (RDIF).

It is noted that clinical trials of the vaccine combination will begin in February 2021.

“The studies are expected to evaluate the immunogenicity and safety of the combined use of the Sputnik V vaccine and the vaccine developed by AstraZeneca in collaboration with the University of Oxford. The research program will last 6 months in several countries, and it is planned to recruit 100 volunteers in each of the studies of the program,” the report says.

RDIF adds that the studies will assess the immunogenicity and safety of the combined use of vaccines.

Formerly RDIF, NITsEM im. N. F. Gamalei, AstraZeneca and R-Pharm signed a memorandum of cooperation in the development of a coronavirus vaccine, which was announced in December 2020 in the presence of Russian President Vladimir Putin.

The world's first vaccine sharing is underway under a clinical trial protocol registered on December 24, 2020.

Новости партнёров